PARP inhibition

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

PARP inhibition

Sep 15, 2024, 23:34 | Insight

Insights from ESMO24 Day 2

The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…

Sep 1, 2024, 20:38 | Blog

Application deadline extended for ESMO Advanced Course on PARP Inhibition

ESMO - European Society for Medical Oncology shared on LinkedIn: "Application deadline extended until 3…

Jul 22, 2024, 08:16 | Blog

Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway Modulation

Maria Natalia Gandur Quiroga shared on X: "Key Findings from the Study on Synergistic Effects of…

May 23, 2024, 12:46 | Blog

ESMO - This novel combination therapy holds great promise for BRCA-mutated metastatic Breast Cancers

ESMO shared a post on LinkedIn: "ESMOBreast24: phase 2 data on combining olaparib, durvalumab, and fulvestrant…

All: 4 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023